Dr. Vinay Prasad to head FDA vaccine, biologics division
Headline from MedicalXpress
The U.S. Food and Drug Administration (FDA) has chosen Dr. Vinay Prasad, a professor at the University of California-San Francisco, to lead its Center for Biologics Evaluation and Research.
MedicalXpress's own description from its feed. We collect headlines and these descriptions, not full articles; read the original reporting below.
The new FDA vaccine chief, Dr. Vinay Prasad was an outspoken critic of the agency's response to the pandemic, including the former vaccine chief, Dr. Peter Marks.
WASHINGTON (AP) — Dr. Vinay Prasad, a prominent critic of the pharmaceutical industry and the Food and Drug Administration, has been named to oversee the health agency’s program for vaccines and biotech drugs. FDA Commissioner Dr.
WASHINGTON (AP) — Dr. Vinay Prasad, a prominent critic of the pharmaceutical industry and the Food and Drug Administration, has been named to oversee the
The US Food and Drug Administration has named Dr. Vinay Prasad, a hematologist oncologist, to lead its Center for Biologics Evaluation and Research, the division that oversees vaccines and biologic medicines.
FDA Commissioner Marty Makary selected Dr. Vinay Prasad, a prominent critic of COVID-19 boosters, to lead the Center for Biologics Evaluation and Research.
The FDA has named Vinay Prasad, an oncologist who has previously criticized COVID-19 restrictions, as the director of its Center for Biologics Evaluation and Research.
The U.S. Food and Drug Administration (FDA) has chosen Dr. Vinay Prasad, a professor at the University of California-San Francisco, to lead its Center for Biologics Evaluation and Research.
The Food and Drug Administration has named Vinay Prasad, an oncologist who has previously criticized FDA leadership and COVID-19 mandates, as the director of its Center for Biologics Evaluation and
Identical headlines usually mean shared wire copy. They are counted as separate articles but are not independent confirmation.
Dr. Vinay Prasad to head FDA vaccine, biologics division | Since Then